# Enjaymo

NDC: 55292-820
Generic name: sutimlimab-jome
Labeler / Manufacturer: Recordati Rare Diseases, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20220204

FDA application: BLA761164

## Active ingredients

- SUTIMLIMAB: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55292-820"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55292-820
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0a25363a-7781-d9f8-cb1c-be22987bf03b